CGEN Compugen Limited: מכפיל שווי פעילות להכנסות

The EV/Sales trajectory for Compugen Ltd. (CGEN) on GURU.Markets correlates with moderate capacity utilization of antibody synthesis laboratories, while 934.15 reflects the latest metric value. A high barrier to entry is ensured by the patent portfolio and strict FDA oversight. Compugen Ltd. (CGEN) is also developing a science and technology hub, combining AI-driven target discovery with biology to create unique methods for combating tumors.
Compugen Limited - פילוחים אנליטיים ומדדי מפתח (CGEN)

The stable IP monetization strategy led by Anat Cohen-Dayag is reflected in the shift of the EV/Sales ratio for Compugen Ltd. (CGEN). This metric compares the total enterprise value of the business with annual revenue, excluding the impact of leverage. The calculation combines market capitalization and net debt, divided by revenue. Low values signal either undervaluation or a systemic crisis in the model. This tool allows for the identification of institutional accumulation phases of the asset.